[English] 日本語
Yorodumi- EMDB-23909: Structural basis for CSPG4 as a receptor for TcdB and a therapeut... -
+Open data
-Basic information
Entry | Database: EMDB / ID: EMD-23909 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection | |||||||||
Map data | Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection | |||||||||
Sample |
| |||||||||
Function / homology | Function and homology information Chondroitin sulfate biosynthesis / Defective CHST3 causes SEDCJD / Defective CHST14 causes EDS, musculocontractural type / Defective CHSY1 causes TPBS / Dermatan sulfate biosynthesis / Defective B3GALT6 causes EDSP2 and SEMDJL1 / CS/DS degradation / Defective B4GALT7 causes EDS, progeroid type / Defective B3GAT3 causes JDSSDHD / substrate-dependent cell migration ...Chondroitin sulfate biosynthesis / Defective CHST3 causes SEDCJD / Defective CHST14 causes EDS, musculocontractural type / Defective CHSY1 causes TPBS / Dermatan sulfate biosynthesis / Defective B3GALT6 causes EDSP2 and SEMDJL1 / CS/DS degradation / Defective B4GALT7 causes EDS, progeroid type / Defective B3GAT3 causes JDSSDHD / substrate-dependent cell migration / A tetrasaccharide linker sequence is required for GAG synthesis / glial cell migration / tissue remodeling / ruffle assembly / glucosyltransferase activity / host cell cytosol / Transferases; Glycosyltransferases; Hexosyltransferases / lamellipodium membrane / platelet-derived growth factor receptor signaling pathway / coreceptor activity / cysteine-type peptidase activity / ruffle / lysosomal lumen / host cell endosome membrane / Golgi lumen / positive regulation of peptidyl-tyrosine phosphorylation / toxin activity / collagen-containing extracellular matrix / angiogenesis / Hydrolases; Acting on peptide bonds (peptidases); Cysteine endopeptidases / positive regulation of MAPK cascade / intracellular signal transduction / apical plasma membrane / focal adhesion / lipid binding / protein kinase binding / host cell plasma membrane / cell surface / proteolysis / extracellular exosome / extracellular region / nucleoplasm / membrane / metal ion binding / plasma membrane Similarity search - Function | |||||||||
Biological species | Clostridioides difficile (bacteria) / Homo sapiens (human) | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.17 Å | |||||||||
Authors | Chen P / Jin R | |||||||||
Funding support | United States, 1 items
| |||||||||
Citation | Journal: Nat Commun / Year: 2021 Title: Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection. Authors: Peng Chen / Ji Zeng / Zheng Liu / Hatim Thaker / Siyu Wang / Songhai Tian / Jie Zhang / Liang Tao / Craig B Gutierrez / Li Xing / Ralf Gerhard / Lan Huang / Min Dong / Rongsheng Jin / Abstract: C. difficile is a major cause of antibiotic-associated gastrointestinal infections. Two C. difficile exotoxins (TcdA and TcdB) are major virulence factors associated with these infections, and ...C. difficile is a major cause of antibiotic-associated gastrointestinal infections. Two C. difficile exotoxins (TcdA and TcdB) are major virulence factors associated with these infections, and chondroitin sulfate proteoglycan 4 (CSPG4) is a potential receptor for TcdB, but its pathophysiological relevance and the molecular details that govern recognition remain unknown. Here, we determine the cryo-EM structure of a TcdB-CSPG4 complex, revealing a unique binding site spatially composed of multiple discontinuous regions across TcdB. Mutations that selectively disrupt CSPG4 binding reduce TcdB toxicity in mice, while CSPG4-knockout mice show reduced damage to colonic tissues during C. difficile infections. We further show that bezlotoxumab, the only FDA approved anti-TcdB antibody, blocks CSPG4 binding via an allosteric mechanism, but it displays low neutralizing potency on many TcdB variants from epidemic hypervirulent strains due to sequence variations in its epitopes. In contrast, a CSPG4-mimicking decoy neutralizes major TcdB variants, suggesting a strategy to develop broad-spectrum therapeutics against TcdB. | |||||||||
History |
|
-Structure visualization
Movie |
Movie viewer |
---|---|
Structure viewer | EM map: SurfViewMolmilJmol/JSmol |
Supplemental images |
-Downloads & links
-EMDB archive
Map data | emd_23909.map.gz | 25.1 MB | EMDB map data format | |
---|---|---|---|---|
Header (meta data) | emd-23909-v30.xml emd-23909.xml | 14.9 KB 14.9 KB | Display Display | EMDB header |
FSC (resolution estimation) | emd_23909_fsc.xml | 7.3 KB | Display | FSC data file |
Images | emd_23909.png | 106.2 KB | ||
Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-23909 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-23909 | HTTPS FTP |
-Related structure data
Related structure data | 7ml7MC M: atomic model generated by this map C: citing same article (ref.) |
---|---|
Similar structure data |
-Links
EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
---|---|
Related items in Molecule of the Month |
-Map
File | Download / File: emd_23909.map.gz / Format: CCP4 / Size: 27 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 1.245 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
CCP4 map header:
|
-Supplemental data
-Sample components
-Entire : EM map of TcdB in complex with CSPG4
Entire | Name: EM map of TcdB in complex with CSPG4 |
---|---|
Components |
|
-Supramolecule #1: EM map of TcdB in complex with CSPG4
Supramolecule | Name: EM map of TcdB in complex with CSPG4 / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#2 |
---|
-Supramolecule #2: TcdB
Supramolecule | Name: TcdB / type: complex / ID: 2 / Parent: 1 / Macromolecule list: #1 |
---|---|
Source (natural) | Organism: Clostridioides difficile (bacteria) |
Recombinant expression | Organism: Escherichia coli (E. coli) |
-Supramolecule #3: CSPG4
Supramolecule | Name: CSPG4 / type: complex / ID: 3 / Parent: 1 / Macromolecule list: #2 |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
Recombinant expression | Organism: Mammalian expression vector BsrGI-MCS-pcDNA3.1 (others) |
-Macromolecule #1: Toxin B
Macromolecule | Name: Toxin B / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO EC number: Hydrolases; Acting on peptide bonds (peptidases); Cysteine endopeptidases |
---|---|
Source (natural) | Organism: Clostridioides difficile (bacteria) |
Molecular weight | Theoretical: 228.752531 KDa |
Recombinant expression | Organism: Escherichia coli (E. coli) |
Sequence | String: MSAWSHPQFE KGGGSGGGSG GSAWSHPQFE KLEVLFQGPM SLVNRKQLEK MANVRFRTQE DEYVAILDAL EEYHNMSENT VVEKYLKLK DINSLTDIYI DTYKKSGRNK ALKKFKEYLV TEVLELKNNN LTPVEKNLHF VAIGGQINDT AINYINQWKD V NSDYNVNV ...String: MSAWSHPQFE KGGGSGGGSG GSAWSHPQFE KLEVLFQGPM SLVNRKQLEK MANVRFRTQE DEYVAILDAL EEYHNMSENT VVEKYLKLK DINSLTDIYI DTYKKSGRNK ALKKFKEYLV TEVLELKNNN LTPVEKNLHF VAIGGQINDT AINYINQWKD V NSDYNVNV FYDSNAFLIN TLKKTVVESA INDTLESFRE NLNDPRFDYN KFFRKRMEII YDKQKNFINY YKAQREENPE LI IDDIVKT YLSNEYSKEI DELNTYIEES LNKITQNSGN DVRNFEEFKN GESFNLYEQE LVERWNLAAA SDILRISALK EIG GMYLNV NMLPGIQPDL FESIEKPSSV TVDFWEMTKL EAIMKYKEYI PEYTSEHFDM LDEEVQSSFE SVLASKSDKS EIFS SLGDM EASPLEVKIA FNSKGIINQG LISVKDSYCS NLIVKQIENR YKILNNSLNP AISEDNDFNT TTNTFIDSIM AEANA DNGR FMMELGKYLR VGFFPDVKTT INLSGPEAYA AAYQDLLMFK EGSMNIHLIE ADLRNFEISK TNISQSTEQE MASLWS FDD ARAKAQFEEY KRNYFEGSAG EDDNLDFSQN IVVDKEYLLE KISSLARSSE RGYIHYIVQL QGDKISYEAA CNLFAKT PY DSVLFQKNIE DSEIAYYYNP GDGEIQEIDK YKIPSIISDR PKIKLTFIGH GKDEFNTDIF AGFDVDSLST EIEAAIDL A KEDISPKSIE INLLGCNMFS YSINVEETYP GKLLLKVKDK ISELMPSISQ DSIIVSANQY EVRINSEGRR ELLDHSGEW INKEESIIKD ISSKEYISFN PKENKITVKS KNLPELSTLL QEIRNNSNSS DIELEEKVML TECEINVISN IDTQIVEERI EEAKNLTSD SINYIKDEFK LIESISDALC DLKQQNELED SHFISFEDIS ETDEGFSIRF INKETGESIF VETEKTIFSE Y ANHITEEI SKIKGTIFDT VNGKLVKKVN LDTTHEVNTL NAAFFIQSLI EYNSSKESLS NLSVAMKVQV YAQLFSTGLN TI TDAAKVV ELVSTALDET IDLLPTLSEG LPIIATIIDG VSLGAAIKEL SETSDPLLRQ EIEAKIGIMA VNLTTATTAI ITS SLGIAS GFSILLVPLA GISAGIPSLV NNELVLRDKA TKVVDYFKHV SLVETEGVFT LLDDKIMMPQ DDLVISEIDF NNNS IVLGK CEIWRMEGGS GHTVTDDIDH FFSAPSITYR EPHLSIYDVL EVQKEELDLS KDLMVLPNAP NRVFAWETGW TPGLR SLEN DGTKLLDRIR DNYEGEFYWR YFAFIADALI TTLKPRYEDT NIRINLDSNT RSFIVPIITT EYIREKLSYS FYGSGG TYA LSLSQYNMGI NIELSESDVW IIDVDNVVRD VTIESDKIKK GDLIEGILST LSIEENKIIL NSHEINFSGE VNGSNGF VS LTFSILEGIN AIIEVDLLSK SYKLLISGEL KILMLNSNHI QQKIDYIGFN SELQKNIPYS FVDSEGKENG FINGSTKE G LFVSELPDVV LISKVYMDDS KPSFGYYSNN LKDVKVITKD NVNILTGYYL KDDIKISLSL TLQDEKTIKL NSVHLDESG VAEILKFMNR KGNTNTSDSL MSFLESMNIK SIFVNFLQSN IKFILDANFI ISGTTSIGQF EFICDENDNI QPYFIKFNTL ETNYTLYVG NRQNMIVEPN YDLDDSGDIS STVINFSQKY LYGIDSCVNK VVISPNIYTD EINITPVYET NNTYPEVIVL D ANYINEKI NVNINDLSIR YVWSNDGNDF ILMSTSEENK VSQVKIRFVN VFKDKTLANK LSFNFSDKQD VPVSEIILSF TP SYYEDGL IGYDLGLVSL YNEKFYINNF GMMVSGLIYI NDSLYYFKPP VNNLITGFVT VGDDKYYFNP INGGAASIGE TII DDKNYY FNQSGVLQTG VFSTEDGFKY FAPANTLDEN LEGEAIDFTG KLIIDENIYY FDDNYRGAVE WKELDGEMHY FSPE TGKAF KLEHHHHHH |
-Macromolecule #2: Chondroitin sulfate proteoglycan 4
Macromolecule | Name: Chondroitin sulfate proteoglycan 4 / type: protein_or_peptide / ID: 2 / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
Molecular weight | Theoretical: 82.298305 KDa |
Recombinant expression | Organism: Mammalian expression vector BsrGI-MCS-pcDNA3.1 (others) |
Sequence | String: HHHHHHHHHS GGGSGGGIEG RPSGSASFFG ENHLEVPVAT ALTDIDLQLQ FSTSQPEALL LLAAGPADHL LLQLYSGRLQ VRLVLGQEE LRLQTPAETL LSDSIPHTVV LTVVEGWATL SVDGFLNASS AVPGAPLEVP YGLFVGGTGT LGLPYLRGTS R PLRGCLHA ...String: HHHHHHHHHS GGGSGGGIEG RPSGSASFFG ENHLEVPVAT ALTDIDLQLQ FSTSQPEALL LLAAGPADHL LLQLYSGRLQ VRLVLGQEE LRLQTPAETL LSDSIPHTVV LTVVEGWATL SVDGFLNASS AVPGAPLEVP YGLFVGGTGT LGLPYLRGTS R PLRGCLHA ATLNGRSLLR PLTPDVHEGC AEEFSASDDV ALGFSGPHSL AAFPAWGTQD EGTLEFTLTT QSRQAPLAFQ AG GRRGDFI YVDIFEGHLR AVVEKGQGTV LLHNSVPVAD GQPHEVSVHI NAHRLEISVD QYPTHTSNRG VLSYLEPRGS LLL GGLDAE ASRHLQEHRL GLTPEATNAS LLGCMEDLSV NGQRRGLREA LLTRNMAAGC RLEEEEYEDD AYGHYEAFST LAPE AWPAM ELPEPCVPEP GLPPVFANFT QLLTISPLVV AEGGTAWLEW RHVQPTLDLM EAELRKSQVL FSVTRGARHG ELELD IPGA QARKMFTLLD VVNRKARFIH DGSEDTSDQL VLEVSVTARV PMPSCLRRGQ TYLLPIQVNP VNDPPHIIFP HGSLMV ILE HTQKPLGPEV FQAYDPDSAC EGLTFQVLGT SSGLPVERRD QPGEPATEFS CRELEAGSLV YVHRGGPAQD LTFRVSD GL QASPPATLKV VAIRPAIQIH RSTGLRLAQG SAMPILPANL SVETNAVGQD VSVLFRVTGA LQFGELQKQG AGGVEGAE W WATQAFHQRD VEQGRVRYLS TDPQHHAYDT VENLALEVQ |
-Macromolecule #3: ZINC ION
Macromolecule | Name: ZINC ION / type: ligand / ID: 3 / Number of copies: 1 / Formula: ZN |
---|---|
Molecular weight | Theoretical: 65.409 Da |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
Processing | single particle reconstruction |
Aggregation state | particle |
-Sample preparation
Buffer | pH: 7.5 |
---|---|
Vitrification | Cryogen name: ETHANE |
-Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELDBright-field microscopy |
Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 46.0 e/Å2 |
Experimental equipment | Model: Titan Krios / Image courtesy: FEI Company |